Peer Review History
| Original SubmissionNovember 3, 2025 |
|---|
|
Dear Dr. Sigudu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.-->--> -->-->3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.-->--> -->-->4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. ?> Additional Editor Comments: In addition to addressing the reviewers’ comments, please ensure the following points are corrected in the revised version of the manuscript:
[Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: General Overview The manuscript presents a retrospective investigation of the annual seroprevalence of Brucella abortus and examines its seasonal and spatial variations across the 17 local municipality areas in Mpumalanga Province, South Africa, over a four-year period. The authors clearly articulate the study objectives and address an important knowledge gap, as this represents one of the first detailed analyses of B. abortus dynamics within the province. The topic is both timely and relevant, contributing valuable epidemiological insights to the national brucellosis control strategy. Methodology The methodology section is clear, concise, and logically structured. The authors provide a well-defined description of the sampling process, noting that samples were obtained by provincial veterinary officials as part of routine surveillance and disease control activities. Since no animals were handled directly for research purposes, the study appropriately sought and obtained ethical approval for access to and analysis of the secondary data. Sample collection and laboratory processing are reported to have adhered to standard operating procedures, and serological testing was conducted following internationally recognized guidelines established by the World Organization for Animal Health (WOAH). This strengthens the scientific validity and comparability of the findings. Operational variables were explicitly defined, the analytical software was identified, and the statistical methods were described in sufficient detail to allow replication. While the field procedures cannot be reproduced- given the retrospective nature of the study- the analytical component of the research demonstrates commendable statistical rigor and transparency. Results The results are clearly presented using tables and chronologically aligned with the stated objectives. Footnotes were provided for abbreviations in corresponding tables, enhancing readability. However, there appears to be a discrepancy in Table 3, which reports the distribution of brucellosis seropositivity by local municipality area. The table indicates that Emalahleni had the highest proportion of positive samples (13.3%), yet it was described as ranking second to Victor Khanye (12.99%) in the text. This inconsistency should be reviewed and corrected for accuracy. Discussion The discussion is robust and insightful. The authors effectively interpret their findings in the context of previous research, providing explanations for observed patterns and highlighting epidemiological implications. The authors acknowledge the limitations of their study, including those inherent to the retrospective data and propose relevant, actionable recommendations for improving brucellosis control strategies in Mpumalanga Province. References The reference list is generally comprehensive; however, some corrections need to be made to ensure accuracy and consistency: • DOIs for references 1, 2, 14, and 36 should be verified. • Hyperlinks attached to references 5 and 6 incorrectly open references 9 and 10, respectively. • Full author lists should be provided for references 22 and 26. • The publication year for reference 23 should be corrected to 2022. • Appropriate citation is required for the academic dissertation for reference 25. • Reference 29 also requires complete citation. In addition, I recommended that the authors update their reference list to include more recent studies, preferably from the past five years- to ensure the discussion reflects the most current developments in brucellosis surveillance and epidemiology. Overall, this manuscript is well-written, methodologically sound, and scientifically relevant. The authors successfully communicate the potential impact of their research in informing strategically targeted interventions for Brucella abortus control in Mpumalanga Province. The study’s conclusions are substantiated by the data presented and offer valuable insights that can be adapted to similar settings both locally and internationally. Recommendation: Accept with minor revisions- to address the discrepancy noted under table 3 in the result section and the reference inconsistencies. Reviewer #2: This manuscript presents a well-executed and highly relevant epidemiological analysis of bovine brucellosis in Mpumalanga Province, South Africa. The study fills a documented gap in provincial-level surveillance data and provides valuable One Health insights. The work is technically sound, methodologically appropriate, and well aligned with PLOS ONE’s scope. Below are major and minor comments intended to strengthen clarity, transparency, and reproducibility. MAJOR COMMENTS 1. Introduction The introduction provides a comprehensive review of brucellosis epidemiology, diagnostic tools, and regional challenges. It establishes relevance for Mpumalanga Province. Literature is current and relevant (adequate citations from 2019–2024). Objective is clearly stated in the final paragraph and aligns well with the methods and results. Recommendation: Justification for the period 2021–2024 is missing. Could include: More regional context Link to national control programs (e.g., OBP vaccination, DAFF surveillance efforts) Socioeconomic implications 2. Methods Strengths: Study design clearly defined (retrospective cross-sectional). Variables (year, season, LMA) clearly operationalized. Data source and processing described coherently. Ethical approval included and appropriate. Recommendations: Clarify whether confirmatory CFT was ever used during 2021–2024, and whether any positives were cross-verified. Consider adding an explicit statement on replicability, e.g., availability of Stata code. 3. Statistical Analysis Strengths: Logistic regression is appropriate for binary seropositivity data. Reporting of OR, AOR, and 95% CI is correct. Seasonal effect modelling is well justified. Points that may need clarification: The multivariate model shows unexpected directionality for seasonal risk (Spring AOR less than Autumn). Authors should briefly discuss potential multicollinearity or sampling pattern effects. Confirm sample sizes per season used in the adjusted model. 4. Results Strengths: Results follow the same order as objectives (temporal → seasonal → spatial → regression). Tables are well organized. Confidence intervals and percentages are correctly calculated. Points needing attention: Some table footnotes should include definitions of abbreviations (e.g., CI, OR, AOR). Table 5 seasonal findings should be more clearly explained given the shift in significance after adjustment. 5. Discussion Strengths: Excellent contextualization within South African and global literature. Provides plausible biological and programmatic explanations. Limitations are clearly acknowledged (sampling bias, reliance on RBT, lack of confirmatory tests). Recommendations: Global patterns in brucellosis prevalence Possible drivers of observed trends (movement control, biosecurity, veterinary service access) Discussion is slightly long; consider tightening sections that repeat results. The discussion of RBT limitations could benefit from referencing test sensitivity/specificity estimates. 6. Conclusion Strong, evidence-driven conclusion. Practical policy recommendations clearly follow from the findings Well aligned with One Health principles. 7. References Mostly recent and relevant. A few references require verification or updated DOI and could be more recent. Recommend replacing citations marked “unable to verify” with peer-reviewed alternatives. MINOR COMMENTS Some long paragraphs could be shortened for readability. Ensure consistent formatting of percentages and CI ranges. Add units (e.g., %, n/N) when reporting Seropositivity. Recommendation Minor Revision The manuscript is strong in relevance and potential impact and requires some revisions for moderate clarifications before publication. The core study is publishable after these improvements. for clarity, methodological transparency, and scientific rigor. Reviewer #3: Recommendation: Major Revision Summary of the Manuscript The authors present a retrospective cross-sectional analysis of bovine brucellosis seropositivity using Rose Bengal Test (RBT) results from 2021–2024 in Mpumalanga Province, South Africa. The study examines temporal (annual), seasonal, and spatial patterns of seropositivity and uses logistic regression to assess associations with year, season, and Local Municipality Area (LMA). The stated research aims are clear and relevant, and the topic is important for provincial disease control and One Health planning. Overall Assessment The manuscript addresses a significant gap in provincial-level brucellosis epidemiology and is based on a large dataset with clear public health relevance. The objectives are well articulated and the general epidemiologic structure (Introduction–Methods–Results–Discussion–Conclusion) is appropriate. However, major revisions are required to address: • Internal inconsistencies in the regression results and their interpretation • Insufficient detail in the Methods to allow reproducibility • Limited spatial/geospatial analysis despite strong emphasis on spatial trends • Outdated, incomplete, and incorrect references • Missing table footnotes/abbreviation definitions and minor reporting issues Major Comments Methods Although the study is retrospective, the Methods section does not provide enough detail for another investigator to reproduce the analysis. • The dependent (RBT seropositivity) and independent variables (year, season, LMA) are not clearly and explicitly defined as model variables, including all categories and reference groups. • Data handling and cleaning procedures are not described: it is unclear how missing data, incomplete records, repeat/duplicate submissions, or batch-level data were managed and converted to the analytical dataset, and steps taken to ensure data quality and consistency. • Season classification is ambiguous: although seasons are said to be derived from the sample date, it is not specified whether this refers to the date of collection or the date received/tested at the laboratory. • There is no description of how LMAs were coded, whether clustering by herd or LMA was considered, or whether random-effects or other hierarchical structures were explored. • The authors mention using the Hosmer–Lemeshow test and AUC to assess model fit, the numerical results of these diagnostics are not reported. Including these values would strengthen transparency and allow readers to properly evaluate model performance. Recommendation: Provide a clearer description of data preprocessing (inclusion/exclusion criteria, duplicates, missing data), explicit model variable definitions and coding (including reference categories), season derivation, and model diagnostics. Results There are important internal inconsistencies in the results: • The text in the Methods suggests winter as the reference season, whereas Table 5 appears to use autumn as the reference. Can you explain why the reference season is different for both analysis? • These discrepancies suggest issues with variable coding, reference category selection, or misreporting of model outputs. P-values are not clearly reported or interpreted, and the Results do not explicitly state which predictors were statistically significant and not statistically significant. Recommendation: Verify and, if needed, re-run the logistic regression models with clearly specified reference categories. Ensure consistency between tables, text, and interpretation. Report p-values or significance indicators and clearly identify which predictors are statistically significant. Revise the Results text accordingly, including more explicit interpretation of odds ratios (e.g., “2023 had approximately twice the odds of seropositivity compared with 2021”). Spatial analysis Spatial patterns are currently presented only in table form (e.g., Table 3). While this is useful for exact values, it is inadequate for a study emphasizing spatial and “hotspot” analysis. Recommendation: Add at least a geographic map of Local Municipality Areas (LMAs) with seropositivity distribution (e.g., choropleth of LMA-level seropositivity) to visualize spatial heterogeneity and highlight potential hotspots. Ideally, basic spatial analysis or clustering assessment should be considered, but at minimum a clear map is needed to support spatial claims. Discussion The Discussion is generally comprehensive, well-structured, and demonstrates a strong understanding of bovine brucellosis epidemiology. However, it requires revision to better reflect the corrected statistical outputs and data limitations. • Explanations invoking vaccination lapses, movement, or biosecurity issues are plausible but speculative, given these data were not collected; such statements should be presented as hypotheses rather than established drivers. • Claims of spatial “hotspots” should be tempered until supported by appropriate visualization or spatial analysis. • Some paragraphs are lengthy and repeat numerical findings rather than focusing on interpretation. Recommendation: Align all interpretations with the corrected regression outputs and descriptive data; soften causal language; reduce repetition; and explicitly integrate the main limitations (sampling bias, use of RBT only, missing contextual variables, lack of spatial modelling) into the interpretative narrative. Strengths and Limitations The strengths and limitations section is generally well written and provides a balanced assessment of the study. The authors appropriately highlight the key advantages of the work, including the use of a large, multi-year dataset, wide geographic coverage, and standardized laboratory procedures. The discussion of limitations related to the use of RBT as a sole screening tool, potential sampling bias in routine submissions, and the absence of herd-level contextual variables is accurate and relevant. However, there are several areas that require improvement: • Data-quality limitations inherent to routine laboratory records (incomplete metadata, inconsistent reporting, possible duplicate submissions) are not explicitly mentioned. • While the authors mention the absence of spatial modelling, it would be helpful to note that the study also lacks geospatial visualisation (e.g., maps), which restricts the ability to meaningfully interpret spatial heterogeneity. • “Seropositivity” should not be capitalized, and some sentences in the strengths paragraph are overly long. More concise phrasing would improve readability. Recommendation: Add brief statements noting variable data quality in routine surveillance systems and the lack of spatial visualization/modelling as constraints on interpretation. Conclusion The Conclusions are clear and generally well structured, but several statements require refinement. The seasonal and spatial interpretations should be presented more cautiously, as the current regression results do not fully support higher odds in warmer months and no spatial visualization was provided. Some recommendations also imply causality, which is not appropriate for a retrospective observational study. The Conclusions would be strengthened by more explicitly acknowledging key limitations such as sampling bias, the absence of confirmatory testing, and lack of herd-level metadata and by clearly outlining areas for future work. In particular, prospective studies, incorporation of confirmatory diagnostics, geospatial modelling, and richer epidemiological metadata should be highlighted as essential next steps to enhance the precision and interpretability of surveillance in Mpumalanga. References: Outdated, inconsistent, and occasionally incorrect The reference list requires substantial revision: • Many references are older than 10 years; more recent literature (last 5 years) on brucellosis in Africa, diagnostics, One Health, and provincial surveillance should be incorporated. • Several references are incorrect or incomplete (Reference 2 not relevant to brucellosis epidemiology and should be replaced, Reference 5 with a URL that does not match the journal title, Reference 7 not in PLOS format, Reference 11 lacking DOI, author must verify accuracy, Reference 25 not identifiable, Reference 29 author must verify accuracy, Reference 36 DOI is incorrect; verify from journal website or CrossRef). Recommendation: Systematically verify all references, correct formatting to PLOS style, ensure that URLs correspond to the cited journal, and replace unverifiable or non–peer-reviewed sources with appropriate peer-reviewed literature. Aim for ≥80% of references from the last 5 years where possible. Minor Comments • “Seropositivity” should not be capitalised. • Ensure consistent terminology (seropositivity vs seroprevalence) and consistent formatting of percentages (e.g., 10.5% rather than 10.5 %). • Tables should include footnotes defining all abbreviations (CI, LMA, RBT, OR, AOR) and specifying the reference categories for regression models. • Consider adding a figure for annual seroprevalence trends over time. • The citation for the Animal Diseases Act should include the full government gazette reference. • Some sentences in the Introduction, Discussion, and Strengths/Limitations sections are overly long and can be made more concise. Overall Recommendation In summary, this manuscript has clear aims and addresses an important topic with a valuable dataset. However, major revisions are required to correct statistical inconsistencies, improve methodological transparency, strengthen the spatial analysis, update and verify references, and align the Discussion and limitations with the actual data and model outputs. In addition, the Ethics Statement is appropriate and clearly describes the approval process and use of anonymized routine laboratory data. The Data Availability statement is generally adequate, though the authors should ensure all analytical code referenced is fully accessible to support reproducibility. The Acknowledgements section is acceptable. The Funding and Competing Interests statements are clear and meet journal requirements. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Dear Dr. Sigudu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 18 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with 2. relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: In addition to addressing all reviewer comments, please ensure that line numbers are included throughout the revised manuscript to facilitate the review process. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: References are important in research as they provide evidence, facilitate the exploration of various sources, and establish credibility within the academic community. However, the comments regarding the reference section in the initial review were overlooked. Therefore, I recommend minor revisions to address these issues. Reviewer #2: The authors should be commended for their thorough and constructive engagement with reviewer feedback. The revised manuscript demonstrates substantial improvement across all previously identified areas of concern. Key improvements since the previous round include: Explicit definition of dependent and independent variables and reference categories Clear justification for batch-level analysis and the inability to perform multilevel modelling Appropriate use of univariate and multivariable logistic regression Reporting of model diagnostics (Hosmer–Lemeshow test and AUC) Explicit discussion of collinearity, correlated predictors, and unequal seasonal sample sizes The revised interpretation of seasonal effects particularly the attenuation and direction change after adjustment is now statistically sound and carefully explained. The Methods section is now comprehensive and reproducible, with clear variable definitions, data cleaning procedures, and modelling decisions. Statistical inconsistencies identified in the previous round have been corrected, and interpretations are now aligned with the final model specification. The addition of a choropleth map appropriately complements the tabular spatial analysis and supports descriptive claims without overstating inference. The Discussion and Conclusion have been carefully revised to avoid causal language and speculative claims, with limitations clearly acknowledged and integrated. The conclusions are well supported by the data and are framed cautiously as associations rather than causal effects. Claims regarding temporal trends, seasonal variability, and spatial heterogeneity are consistent with the descriptive and regression results presented. Overinterpretation has been avoided, particularly with respect to seasonal drivers and spatial “hotspots.” Overall, the manuscript now provides a robust, transparent, and policy-relevant epidemiological description of bovine brucellosis patterns in Mpumalanga Province and represents a valuable contribution to the literature on routine surveillance data use in endemic settings. I have no further substantive comments and support publication. Reviewer #3: The authors have made meaningful progress in addressing the major concerns raised in the initial review. Methodological transparency has improved, with clearer variable definitions, data preprocessing descriptions, and more consistent reporting of logistic regression results. Internal inconsistencies between tables and text have largely been resolved, and statistical interpretations are now clearer and more accurate. The inclusion of spatial visualization strengthens the presentation of geographic patterns, although claims regarding spatial “hotspots” remain appropriately cautious given the absence of formal spatial modelling. The Discussion and Conclusions are better aligned with the corrected results and more clearly distinguish observed associations from speculative explanations. Additional Comments Reference formatting and numbering: Reference formatting remains inconsistent. Citations are not numbered and ordered consistently in accordance with their first appearance in the text, and several in-text citations do not clearly correspond to the reference list. The authors should carefully renumber all references sequentially, ensure one-to-one correspondence between in-text citations and the reference list, and confirm that all references adhere strictly to the journal’s formatting requirements. Several cited sources appear to predate the last five years. The authors should ensure that the majority of references reflect recent literature and clearly justify the inclusion of older sources. Strengths and limitations: The manuscript does not include a clearly outlined Strengths and Limitations section. Given the nature of the data and study design, a dedicated subsection is necessary to explicitly summarize methodological strengths and key limitations. This section would improve transparency and aid interpretation of the findings. Overall, the manuscript now represents a substantially improved and policy-relevant contribution and is suitable for publication pending minor revision. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 27 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please remove all subheadings from the Discussion section, including “Strengths and Limitations of the Study.” The study limitations should be presented as the final paragraph of the Discussion. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Bovine Brucellosis Seropositivity in Mpumalanga Province, South Africa, 2021–2024: Temporal, and Spatial Trends PONE-D-25-59216R3 Dear Dr. Sigudu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-59216R3 PLOS One Dear Dr. Sigudu, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mabel Kamweli Aworh Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .